Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Employer
-
Field
-
NORPOD is a collaborative postdoctoral program of the Nordic EMBL Partnership for Molecular Medicine . The partnership is a network of four national research centers across the Nordics and the
-
Galej at the EMBL Grenoble, France. We are looking for a highly motivated and ambitious individual to join our team interested in the structure and function of RNA-protein complexes. Our group
-
the patients in the Nordic hospitals. NORPOD is a collaborative postdoctoral program of the Nordic EMBL Partnership for Molecular Medicine . The partnership is a network of four national research centers across
-
NORPOD is a collaborative postdoctoral program of the Nordic EMBL Partnership for Molecular Medicine . The partnership is a network of four national research centers across the Nordics and the
-
NORPOD is a collaborative postdoctoral program of the Nordic EMBL Partnership for Molecular Medicine . The partnership is a network of four national research centers across the Nordics and the
-
: _vid_t Leverandør: .jobbnorge.no Databehandlingsansvarlig: Formål: Saves the selected language for the website. Utløpsdato: én måned Navn: jobbnorge.language Leverandør: .jobbnorge.no
-
for databehandling: Piwik Pro - Personvernregler for databehandling Utløpsdato: ett år Navn: _pk_idxxx Leverandør: www.jobbnorge.no Databehandlingsansvarlig: Formål: Saves the selected language for the website
-
Postdoc in CRISPR Meta-Analytics and AI for Therapeutic Target Discovery and Priotisation (OT Grant)
cancers and other diseases. Together with researchers at EMBL – European Bioinformatics Institute and Wellcome Sanger Institute , our lab has recently been awarded an Open Targets Research Grant funding
-
for databehandling: Piwik Pro - Personvernregler for databehandling Utløpsdato: ett år Navn: _pk_idxxx Leverandør: www.jobbnorge.no Databehandlingsansvarlig: Formål: Saves the selected language for the website
-
is a close collaboration between the Systems Ecology group (head: Paul Wilmes, Luxembourg, the Molecular Disease Mechanisms group (co-head: Elisabeth Letellier, Luxembourg), the EMBL-EBI's Microbiome